Open AccessMethotrexate monotherapy for unilateral moderately active thyroid‐related eye disease
Author(s) -
Elnahry Ayman G.,
Talbet Joseph H.,
Elnahry Gehad A.
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4559
Subject(s) - medicine , methotrexate , adverse effect , thyroid , thyroid disease , eye disease , surgery
A type 1 diabetic patient with unilateral active thyroid‐related eye disease was intolerant to systemic steroid therapy due to uncontrollable blood sugar levels. She was treated with low‐dose methotrexate monotherapy, which resulted in a marked improvement of her condition with no adverse events.